Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesNovel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and functionD-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation.Jiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay miceS100A12 mediates aortic wall remodeling and aortic aneurysm.Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAHReceptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cellsOn the significance of new biochemical markers for the diagnosis of premature labour.Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgerySoluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast CellsArterial Stiffness, Distensibility, and Strain in Asthmatic Children.sRAGE induces human monocyte survival and differentiationRAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.Diagnostic Potential of Evaluation of SDF-1α and sRAGE Levels in Threatened Premature Labor.Use of human vascular tissue microarrays for measurement of advanced glycation endproductsThe pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuliOxidative stress in diabetes and Alzheimer's disease.Diabetes, insulin, and development of acute lung injury.Analytic review: glucose controversies in the ICU.Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.Soluble and Endogenous Secretory Receptors for Advanced Glycation End Products in Threatened Preterm Labor and Preterm Premature Rupture of Fetal MembranesImaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.Arterial calcification is driven by RAGE in Enpp1-/- mice.Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigsIncrease of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage.The influence of diabetes on degree of abdominal aortic aneurysm tissue inflammation.Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.Vascular biomarkers in the metabolic syndrome.Continuous positive air pressure treatment reduces serum advanced glycation end products in patients with obstructive sleep apnoea syndrome: a pilot study.Grape seed proanthocyanidin extracts prevent hyperglycemia-induced monocyte adhesion to aortic endothelial cells and ameliorates vascular inflammation in high-carbohydrate/high-fat diet and streptozotocin-induced diabetic rats.Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
P2860
Q21285070-34F35F8C-9E08-4D5B-8AFD-D1AFB764839BQ28286769-406169C0-1CF9-43AE-B46C-543BA09705B4Q30575300-01A68F22-A1F5-485C-ABBC-BF717F781219Q33706208-5B22051D-4EAF-4417-88FB-8FF9838A3A03Q33883852-E0E54C50-7673-415C-B5DF-E8FD3A527B9AQ34133874-F152736D-ED10-434F-9887-18BCBBFF3683Q34188756-7078DCB8-A327-4F3E-A68B-88A23206091DQ34762626-A6D1F156-1D14-4569-8015-32E7CEDD3D3DQ35068413-C43F56BE-41A4-4AB9-933F-5D65DE9E57BDQ35658848-A22798B2-B69D-4373-BB62-49DF7A203825Q35737906-3DED3759-F766-4DD6-B1FE-0BDAF6E210A3Q35896615-E322D72B-3FEF-4FCA-9AE4-CB0CB1C96D3AQ35970395-990927C9-2EAE-45D7-8D81-37527A0D188CQ36514614-F5EAA9E8-C7D7-47C5-929D-CD790EDAC7B7Q36900801-9A829A21-6767-4F41-B08A-A1A8B138124FQ37152947-1E7889B1-D3D9-4C3D-8523-3075CB8EF62DQ37172011-43664F18-1FD6-4D42-A052-1EEC7334F5CEQ37212344-8DDBFCCC-BE0E-4FC0-AC00-D1B8A13E3D0BQ37231824-78A29207-0E53-46AA-B4DA-A354BF98FAA4Q37455830-35C33E5A-F9DE-4DF1-9D0B-5A3B86169CC2Q37521491-9E32721F-9F1E-445E-8E87-DBBB5B9F7752Q37813868-0825930B-A522-44A3-AB31-A69F1A49EF2AQ39727356-65E1FA80-ABE6-4184-88EF-3933E1CAD61EQ40977776-7EA53D9E-490E-4446-9EFD-A64C08C67FBEQ40979636-77DFA65D-5485-4203-A5E3-B7BCA2911CD6Q41202872-78067FFF-AD61-4917-89EA-31502ACB1729Q42013140-50C07FBC-8547-4321-9261-AE11F89BC11FQ42177725-2DE17C6B-2691-438C-ACDC-D52186EB0AD3Q42906443-1396960D-C96D-4870-A7C1-8C2A61E931B4Q44106187-14A8A225-F598-4364-A1B0-3F0F7C82D98AQ45339625-4FA81827-746D-458B-B8AC-13050F5DCAFCQ46044501-BECDAF90-1937-41A8-BEF3-E173F1CAA888Q48311123-F10D453E-8B29-4940-BDDF-34157F8B0E56Q53113438-923CDC4F-9A3F-4DC7-9E18-442B17B09E3FQ53646889-97E18046-0BBE-4ACD-8530-289112BADDC3
P2860
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Receptor for advanced glycatio ...... sfunction and atherosclerosis.
@en
type
label
Receptor for advanced glycatio ...... sfunction and atherosclerosis.
@en
prefLabel
Receptor for advanced glycatio ...... sfunction and atherosclerosis.
@en
P2093
P2860
P356
P1476
Receptor for advanced glycatio ...... sfunction and atherosclerosis.
@en
P2093
Ann Marie Schmidt
Kevan Herold
Raphael Clynes
Ravichandran Ramasamy
Shi Fang Yan
P2860
P356
10.1196/ANNALS.1433.056
P407
P577
2008-04-01T00:00:00Z